Results 11 to 20 of about 264,442 (390)

Metabolomics and a Breath Sensor Identify Acetone as a Biomarker for Heart Failure

Biomolecules, 2022
Background: Multi-omics delivers more biological insight than targeted investigations. We applied multi-omics to patients with heart failure with reduced ejection fraction (HFrEF).
Patrick A. Gladding, Maxine Cooper, Renee Young, Suzanne Loader, Kevin Smith, Erica Zarate, Saras Green, Silas G. Villas Boas, Phillip Shepherd, Purvi Kakadiya, Eric Thorstensen, Christine Keven, Margaret Coe, Mia Jüllig, Edmond Zhang, Todd T. Schlegel   +15 more
doaj   +1 more source

Diabetic microvascular complications predicts non‐heart failure with reduced ejection fraction in type 2 diabetes

ESC Heart Failure, 2023
Aims The relationship between diabetic microvascular complications and the incidence of two types of heart failure—heart failure with reduced ejection fraction (HFrEF) (left ventricular ejection fraction [LVEF] 
Mayu Tochiya, Hisashi Makino, Tamiko Tamanaha, Yoko Omura‐Ohata, Masaki Matsubara, Ryo Koezuka, Michio Noguchi, Tsutomu Tomita, Yasuhide Asaumi, Yoshihiro Miyamoto, Satoshi Yasuda, Kiminori Hosoda   +11 more
doaj   +1 more source

Vericiguat for Heart Failure with Reduced Ejection Fraction [PDF]

Current Cardiology Reports, 2021
AbstractPurpose of ReviewThe nitric oxide (NO)-soluble guanylate cyclase (sGC)-cyclic guanosine monophosphate (cGMP) pathway plays an important role in the regulation of cardiovascular function, and it is disrupted in heart failure (HF), resulting in decreased protection against myocardial injury.
Lombardi C. M., Cimino G., Pagnesi M., Dell'Aquila A., Tomasoni D., Ravera A., Inciardi R., Carubelli V., Vizzardi E., Nodari S., Emdin M., Aimo A.   +11 more
openaire   +4 more sources

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides

Frontiers in Cardiovascular Medicine, 2021
This review summarizes current knowledge regarding clinical epidemiology, pathophysiology, and prognosis for patients with HFmrEF in comparison to HFrEF and HFpEF. Although recommended treatments currently focus on aggressive management of comorbidities,
Kaiyuan Zhu, Teng Ma, Yang Su, Xin Pan, Rongrong Huang, Fenglei Zhang, Chunxi Yan, Dachun Xu, Dachun Xu   +8 more
doaj   +1 more source

Chronic heart failure with reduced ejection fraction [PDF]

Canadian Medical Association Journal, 2014
See also page [510][1] and [www.cmaj.ca/lookup/doi/10.1503/cmaj.131742][2] Heart failure with reduced ejection fraction is a clinical syndrome of dyspnea, exercise intolerance and/or edema resulting from an impairment of ejection of blood, usually documented by a left ventricular ejection ...
Yasbanoo, Moayedi, Jeremy, Kobulnik
openaire   +2 more sources

Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial

European Heart Journal, 2022
Aims To investigate the impact of patiromer on the serum potassium level and its ability to enable specified target doses of renin–angiotensin–aldosterone system inhibitor (RAASi) use in patients with heart failure and reduced ejection fraction (HFrEF ...
J. Butler, S. Anker, L. Lund, A. Coats, G. Filippatos, T. Siddiqi, T. Friede, V. Fabien, M. Kosiborod, M. Metra, I. Piña, F. Pinto, P. Rossignol, P. van der Meer, Cecilia Bahit, J. Bělohlávek, M. Böhm, J. Brugts, J. Cleland, J. Ezekowitz, A. Bayés‐Genís, I. Gotsman, A. Goudev, I. Khintibidze, J. Lindenfeld, R. Mentz, B. Merkely, Eliodoro Castro Montes, W. Mullens, J. Nicolau, A. Parkhomenko, P. Ponikowski, P. Seferovic, M. Senni, E. Shlyakhto, A. Cohen-Solal, P. Szecsödy, K. Jensen, F. Dorigotti, M. Weir, B. Pitt   +40 more
semanticscholar   +1 more source

A comparison of clinical outcomes following atrial fibrillation ablation for heart failure patients with preserved or reduced left ventricular function: A systematic review and meta-analysis

Indian Pacing and Electrophysiology Journal, 2022
Background: This review aims to determine if patients who undergo atrial fibrillation (AF) ablation with heart failure with preserved ejection fraction (HFpEF) do better, or worse or the same compared to patients with heart failure with reduced ejection ...
Gaurav Panchal, Chun Shing Kwok, Adrian Morley-Davies, Donah Zachariah, Thanh Phan   +4 more
doaj   +1 more source

Anthropometric measures and adverse outcomes in heart failure with reduced ejection fraction: revisiting the obesity paradox

European Heart Journal, 2023
Aims Although body mass index (BMI) is the most commonly used anthropometric measure, newer indices such as the waist-to-height ratio, better reflect the location and amount of ectopic fat, as well as the weight of the skeleton, and may be more useful ...
J. Butt, M. Petrie, P. Jhund, N. Sattar, Akshay S. Desai, L. Køber, J. Rouleau, K. Swedberg, M. Zile, S. Solomon, M. Packer, J. McMurray   +11 more
semanticscholar   +1 more source

Five‐year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort

ESC Heart Failure, 2022
Aims Available evidence is incomplete and inconsistent in the outcomes of heart failure (HF) patients with preserved ejection fraction (HFpEF), mildly reduced ejection fraction (HFmrEF), and reduced ejection fraction (HFrEF).
Shiqun Chen, Zhidong Huang, Yan Liang, Xiaoli Zhao, Xiemuxikaimaier Aobuliksimu, Bo Wang, Yibo He, Yu Kang, Haozhang Huang, Qiang Li, Younan Yao, Xiaozhao Lu, Xiaoxian Qian, Xujing Xie, Jin Liu, Yong Liu   +15 more
doaj   +1 more source

Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction

Biomolecules, 2022
Heart failure (HF) is a clinical condition defined by structural and functional abnormalities in the heart that gradually result in reduced cardiac output (HFrEF) and/or increased cardiac pressures at rest and under stress (HFpEF).
Federico Ferro, Renza Spelat, Camilla Valente, Paolo Contessotto   +3 more
doaj   +1 more source